Thermo Fisher Scientific (TMO) Assets Average (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Assets Average for 18 consecutive years, with $113.2 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets Average rose 13.07% year-over-year to $113.2 billion; the trailing twelve-month figure through Jun 2026 stood at $113.2 billion (up 13.07% YoY), and the FY2025 full-year result was $103.8 billion, up 5.93% from the prior year.
• Assets Average improved to $113.2 billion in Q2 2026 per TMO's latest filing, from $111.8 billion in the prior quarter.
• Across five years, Assets Average topped out at $113.2 billion in Q2 2026 and bottomed at $90.6 billion in Q4 2022.
• Historically, Assets Average has averaged $98.9 billion across 5 years, with a median of $97.9 billion in 2023.
• The sharpest annual moves came in 2022 and 2025: Assets Average soared 39.18% in 2022, then advanced 0.28% in 2025.
• Over 5 years, Assets Average stood at $93.8 billion in 2022, then rose by 4.31% to $97.9 billion in 2023, then gained by 0.97% to $98.8 billion in 2024, then rose by 7.93% to $106.7 billion in 2025, then climbed by 6.14% to $113.2 billion in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $113.2 billion, $111.8 billion, and $106.7 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.